Lipid Binding: A Necessary Evil for Broadly Neutralizing Anti-gp41 Antibodies?

Lipid Binding: A Necessary Evil for Broadly Neutralizing Anti-gp41 Antibodies?

Bibliographic Details
Main Authors:	Scherer, E, Mcmichael, A, Burton, DR
Format:	Conference item
Published:	2008

Similar Items

Bispecific Anti-HIV Immunoadhesins That Bind Gp120 and Gp41 Have Broad and Potent HIV-Neutralizing Activity
by: Seth H. Pincus, et al.
Published: (2021-07-01)

Neutralizing Antibodies Targeting HIV-1 gp41
by: Christophe Caillat, et al.
Published: (2020-10-01)

Exposure of the HIV-1 broadly neutralizing antibody 10E8 MPER epitope on the membrane surface by gp41 transmembrane domain scaffolds
by: Oakes, V, et al.
Published: (2018)

Structure of HIV-1 gp41 with its membrane anchors targeted by neutralizing antibodies
by: Christophe Caillat, et al.
Published: (2021-04-01)

A glycoconjugate antigen based on the recognition motif of a broadly neutralizing human immunodeficiency virus antibody, 2G12, is immunogenic but elicits antibodies unable to bind to the self glycans of gp120.
by: Astronomo, R, et al.
Published: (2008)

Anti-HIV double variable domain immunoglobulins binding both gp41 and gp120 for targeted delivery of immunoconjugates.
by: Ryan B Craig, et al.
Published: (2012-01-01)

The Effects of Somatic Hypermutation on Neutralization and Binding in the PGT121 Family of Broadly Neutralizing HIV Antibodies
by: Sok, Devin, et al.
Published: (2014)

Refocusing the Antibody Response: The Use of an Antibody-Masking Technique to Elicit Broadly Neutralizing Antibodies
by: Wan, D, et al.
Published: (2011)

Synergistic Effect by Combining a gp120-Binding Protein and a gp41-Binding Antibody to Inactivate HIV-1 Virions and Inhibit HIV-1 Infection
by: Xinling Wang, et al.
Published: (2021-03-01)

Mechanisms of escape from the PGT128 family of anti-HIV broadly neutralizing antibodies
by: Krumm, S, et al.
Published: (2016)

Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120.
by: Moore, J, et al.
Published: (1995)

Design of immunogens to elicit broadly neutralizing antibodies against HIV targeting the CD4 binding site
by: Conti, Simone, et al.
Published: (2021)

SOLUBLE CD4 BINDING TO HIV-1 VIRIONS CAUSES GP120 TO DISSOCIATE FROM GP41
by: Moore, J, et al.
Published: (1991)

The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120.
by: Scanlan, C, et al.
Published: (2002)

Hyperchloremia, a necessary evil in neurocritical care
by: Gonzalo Ramírez-Guerrero, et al.
Published: (2023-09-01)

A novel form of carbohydrate recognition. The broadly neutralizing anti-HIV-1 antibody 2G12 recognizes a cluster of a1-2 mannose residues on the outer face of GP120
by: Rudd, P, et al.
Published: (2002)

Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies
by: Haynes, BF, et al.
Published: (2022)

The Gp41 Sequence Connecting Mper and Tm Domains Constitutes a Distinct HIV-1 "Fusion Peptide" Targeted by Neutralizing Antibodies
by: Apellaniz, B, et al.
Published: (2014)

Cholesterol-dependent membrane fusion induced by the gp41 membrane-proximal external region-transmembrane domain connection suggests a mechanism for broad HIV-1 neutralization.
by: Apellániz, B, et al.
Published: (2014)

Cataloguing, a necessary evil: critical aspects of RDA
by: Agnese Galeffi, et al.
Published: (2016-05-01)

Cataloguing, a necessary evil: critical aspects of RDA
by: Agnese Galeffi, et al.
Published: (2016-05-01)

Cataloguing, a necessary evil: critical aspects of RDA
by: Agnese Galeffi, et al.
Published: (2016-05-01)

Cataloguing, a necessary evil: critical aspects of RDA
by: Agnese Galeffi, et al.
Published: (2016-05-01)

OUTCOMES-BASED ASSESSMENT: NECESSARY EVIL OR TRANSFORMATIVE POTENTIAL
by: Vivienne Bozalek
Published: (2009-03-01)

Computational Prediction of Broadly Neutralizing HIV-1 Antibody Epitopes from Neutralization Activity Data
by: Ferguson, Andrew L., et al.
Published: (2014)

An aptamer that neutralizes R5 strains of HIV-1 binds to core residues of gp120 in the CCR5 binding site
by: Cohen, C, et al.
Published: (2008)

Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers
by: Elise Landais, et al.
Published: (2018-09-01)

Enhancement of soluble CD4-mediated HIV neutralization and gp 120 binding by CD4 autoantibodies and monoclonal antibodies.
by: Moore, J, et al.
Published: (1990)

B cell repertoire sequencing of HIV-1 pediatric elite-neutralizers identifies multiple broadly neutralizing antibody clonotypes
by: Sanjeev Kumar, et al.
Published: (2024-02-01)

Identification of a broad sarbecovirus neutralizing antibody targeting a conserved epitope on the receptor-binding domain
by: Yanqun Wang, et al.
Published: (2024-01-01)

Contribution of rare mutational outcomes to broadly neutralizing antibodies
by: Feng Anqi, et al.
Published: (2022-06-01)

Optimizing immunization protocols to elicit broadly neutralizing antibodies
by: Sprenger, Kayla G, et al.
Published: (2021)

Solid-state NMR investigation of viral fusion glycoprotein 41 (gp41)
by: Morgan, Chloe A.(Chloe Anne)
Published: (2020)

Role of framework mutations and antibody flexibility in the evolution of broadly neutralizing antibodies
by: Karplus, Martin, et al.
Published: (2018)

Role of framework mutations and antibody flexibility in the evolution of broadly neutralizing antibodies
by: Victor Ovchinnikov, et al.
Published: (2018-02-01)

Identification of Anti-gp41 Monoclonal Antibodies That Effectively Target Cytotoxic Immunoconjugates to Cells Infected with Human Immunodeficiency Virus, Type 1
by: Grant Klug, et al.
Published: (2023-04-01)

PESTICIDES; A NECESSARY EVIL IN THE AGRICULTURAL VALUE CHAIN- A REVIEW
by: Joshua Yeboah Asiamah, et al.
Published: (2020-05-01)

Is the seclusion policy of mental health care users a necessary evil
by: Gaveeta Chiba, et al.
Published: (2015-05-01)

Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design.
by: Joseph G Jardine, et al.
Published: (2016-08-01)

Construction and Characterization of a Humanized Anti-Epstein-Barr Virus gp350 Antibody with Neutralizing Activity in Cell Culture
by: Jerome E. Tanner, et al.
Published: (2018-04-01)